Literature DB >> 29171823

Liraglutide and Renal Outcomes in Type 2 Diabetes.

Johannes F E Mann1, David D Ørsted2, John B Buse3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29171823     DOI： 10.1056/NEJMc1713042

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  The New Biology of Diabetic Kidney Disease-Mechanisms and Therapeutic Implications.

Authors:  Yuliya Lytvyn; Petter Bjornstad; Daniel H van Raalte; Hiddo L Heerspink; David Z I Cherney
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

2.  Premature Death in Kidney Transplant Recipients: The Time for Trials is Now.

Authors:  Amanda J Vinson; Sunita Singh; Steven Chadban; David Cherney; Osama Gaber; John S Gill; Erika Helgeson; Charles A Herzog; Meg Jardine; Vivekanand Jha; Bertram L Kasiske; Roslyn B Mannon; Erin D Michos; Amy K Mottl; Kristin Newby; Prabir Roy-Chaudhury; Deirdre Sawinski; Adnan Sharif; Vikas S Sridhar; Katherine R Tuttle; David M Vock; Arthur Matas
Journal:  J Am Soc Nephrol       Date:  2022-03-15       Impact factor: 14.978

Review 3.  Mechanisms of Cardiorenal Protection of Glucagon-Like Peptide-1 Receptor Agonists.

Authors:  Kalie L Tommerdahl; Kristen J Nadeau; Petter Bjornstad
Journal:  Adv Chronic Kidney Dis       Date:  2021-07       Impact factor: 4.305

Review 4.  Diabetic Kidney Disease: Challenges, Advances, and Opportunities.

Authors:  Ya Chen; Kyung Lee; Zhaohui Ni; John Cijiang He
Journal:  Kidney Dis (Basel)       Date:  2020-03-31

Review 5.  Early microvascular complications in type 1 and type 2 diabetes: recent developments and updates.

Authors:  Kalie L Tommerdahl; Allison L B Shapiro; Edward J Nehus; Petter Bjornstad
Journal:  Pediatr Nephrol       Date:  2021-04-14       Impact factor: 3.714

6.  Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease: A Randomized Placebo-Controlled Clinical Trial.

Authors:  John P Hanrahan; Ian H de Boer; George L Bakris; Phebe J Wilson; James D Wakefield; Jelena P Seferovic; Jennifer G Chickering; Yueh-Tyng Chien; Kenneth Carlson; Michael D Cressman; Mark G Currie; G Todd Milne; Albert T Profy
Journal:  Clin J Am Soc Nephrol       Date:  2020-12-16       Impact factor: 8.237

Review 7.  A narrative review of new treatment options for chronic kidney disease in type 2 diabetes.

Authors:  Frederik Persson; Rikke Borg; Peter Rossing
Journal:  Ann Transl Med       Date:  2021-04

Review 8.  Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data.

Authors:  Anne J Kugler; Michael L Thiman
Journal:  Diabetes Metab Syndr Obes       Date:  2018-05-09       Impact factor: 3.168

Review 9.  A Low-Protein Diet for Diabetic Kidney Disease: Its Effect and Molecular Mechanism, an Approach from Animal Studies.

Authors:  Munehiro Kitada; Yoshio Ogura; Itaru Monno; Daisuke Koya
Journal:  Nutrients       Date:  2018-04-27       Impact factor: 5.717

10.  The variability of glycated hemoglobin is associated with renal function decline in patients with type 2 diabetes.

Authors:  Chia-Lin Lee; Cheng-Hsu Chen; Ming-Ju Wu; Shang-Feng Tsai
Journal:  Ther Adv Chronic Dis       Date:  2020-03-03       Impact factor: 5.091
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.